Report Detail
Global Bacterial Vaginosis Drugs Market Insights, Forecast to 2025
- RnM3488038 |
- 04 June, 2019 |
- Global |
- 114 Pages |
- QYResearch |
- Pharma & Healthcare
Bacterial vaginosis is an imbalance of "good" and "bad" bacteria in the vagina, with there being more bad bacteria. Causes of an imbalance of bacteria can be caused by multiple sex partners and douching. Symptoms include odor, discharge, burning, and itching. Treatments for bacterial vaginosis include the use of probiotics and medication. Common drug classes include lincosamide antibiotics and nitroimidazole antibiotics.
One driver in the market is unmet demand in BV treatment market. Unmet demand in the treatment of BV has created great opportunity for the market players. There is huge unmet need in the treatment of BV, especially the recurrent form of the disease. BV is the most common vaginal infection in the women of child bearing age group. Despite being highly prevalent in nature, little has been done in the field. When left untreated, it may lead to severe infections, especially in the case of pregnant women such as preterm births. rising awareness about women's health as one of the primary growth factors for the bacterial vaginosis drugs market. Owing to recent advancements in healthcare and the initiatives taken by the government and non-government organizations to increase the awareness about health of women, the demand for pharmaceuticals related to disorders in women will witness a significant increase in the coming years. Additionally, support from government is also a key driver.
The global Bacterial Vaginosis Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Bacterial Vaginosis Drugs market based on company, product type, end user and key regions.
This report studies the global market size of Bacterial Vaginosis Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Bacterial Vaginosis Drugs in these regions.
This research report categorizes the global Bacterial Vaginosis Drugs market by top players/brands, region, type and end user. This report also studies the global Bacterial Vaginosis Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Bayer
Pfizer
Sanofi
Starpharma Holdings
Market size by Product
Oral
Topical
Market size by End User
Pelvic Inflammatory Disease
Preterm Delivery of Infants
Urinary Tract Infection
Sexually Transmitted Diseases (STD)
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Bacterial Vaginosis Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Bacterial Vaginosis Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Bacterial Vaginosis Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Bacterial Vaginosis Drugs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Bacterial Vaginosis Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Bacterial Vaginosis Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Bacterial Vaginosis Drugs Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Bacterial Vaginosis Drugs Market Size Growth Rate by Product
- 1.4.2 Oral
- 1.4.3 Topical
- 1.5 Market by End User
- 1.5.1 Global Bacterial Vaginosis Drugs Market Size Growth Rate by End User
- 1.5.2 Pelvic Inflammatory Disease
- 1.5.3 Preterm Delivery of Infants
- 1.5.4 Urinary Tract Infection
- 1.5.5 Sexually Transmitted Diseases (STD)
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Bacterial Vaginosis Drugs Market Size
- 2.1.1 Global Bacterial Vaginosis Drugs Revenue 2014-2025
- 2.1.2 Global Bacterial Vaginosis Drugs Sales 2014-2025
- 2.2 Bacterial Vaginosis Drugs Growth Rate by Regions
- 2.2.1 Global Bacterial Vaginosis Drugs Sales by Regions
- 2.2.2 Global Bacterial Vaginosis Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Bacterial Vaginosis Drugs Sales by Manufacturers
- 3.1.1 Bacterial Vaginosis Drugs Sales by Manufacturers
- 3.1.2 Bacterial Vaginosis Drugs Sales Market Share by Manufacturers
- 3.1.3 Global Bacterial Vaginosis Drugs Market Concentration Ratio (CR5 and HHI)
- 3.2 Bacterial Vaginosis Drugs Revenue by Manufacturers
- 3.2.1 Bacterial Vaginosis Drugs Revenue by Manufacturers (2014-2019)
- 3.2.2 Bacterial Vaginosis Drugs Revenue Share by Manufacturers (2014-2019)
- 3.3 Bacterial Vaginosis Drugs Price by Manufacturers
- 3.4 Bacterial Vaginosis Drugs Manufacturing Base Distribution, Product Types
- 3.4.1 Bacterial Vaginosis Drugs Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Bacterial Vaginosis Drugs Product Type
- 3.4.3 Date of International Manufacturers Enter into Bacterial Vaginosis Drugs Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Bacterial Vaginosis Drugs Sales by Product
- 4.2 Global Bacterial Vaginosis Drugs Revenue by Product
- 4.3 Bacterial Vaginosis Drugs Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Bacterial Vaginosis Drugs Breakdown Data by End User
6 North America
- 6.1 North America Bacterial Vaginosis Drugs by Countries
- 6.1.1 North America Bacterial Vaginosis Drugs Sales by Countries
- 6.1.2 North America Bacterial Vaginosis Drugs Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Bacterial Vaginosis Drugs by Product
- 6.3 North America Bacterial Vaginosis Drugs by End User
7 Europe
- 7.1 Europe Bacterial Vaginosis Drugs by Countries
- 7.1.1 Europe Bacterial Vaginosis Drugs Sales by Countries
- 7.1.2 Europe Bacterial Vaginosis Drugs Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Bacterial Vaginosis Drugs by Product
- 7.3 Europe Bacterial Vaginosis Drugs by End User
8 Asia Pacific
- 8.1 Asia Pacific Bacterial Vaginosis Drugs by Countries
- 8.1.1 Asia Pacific Bacterial Vaginosis Drugs Sales by Countries
- 8.1.2 Asia Pacific Bacterial Vaginosis Drugs Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Bacterial Vaginosis Drugs by Product
- 8.3 Asia Pacific Bacterial Vaginosis Drugs by End User
9 Central & South America
- 9.1 Central & South America Bacterial Vaginosis Drugs by Countries
- 9.1.1 Central & South America Bacterial Vaginosis Drugs Sales by Countries
- 9.1.2 Central & South America Bacterial Vaginosis Drugs Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Bacterial Vaginosis Drugs by Product
- 9.3 Central & South America Bacterial Vaginosis Drugs by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Bacterial Vaginosis Drugs by Countries
- 10.1.1 Middle East and Africa Bacterial Vaginosis Drugs Sales by Countries
- 10.1.2 Middle East and Africa Bacterial Vaginosis Drugs Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Bacterial Vaginosis Drugs by Product
- 10.3 Middle East and Africa Bacterial Vaginosis Drugs by End User
11 Company Profiles
- 11.1 Bayer
- 11.1.1 Bayer Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Bayer Bacterial Vaginosis Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Bayer Bacterial Vaginosis Drugs Products Offered
- 11.1.5 Bayer Recent Development
- 11.2 Pfizer
- 11.2.1 Pfizer Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Pfizer Bacterial Vaginosis Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Pfizer Bacterial Vaginosis Drugs Products Offered
- 11.2.5 Pfizer Recent Development
- 11.3 Sanofi
- 11.3.1 Sanofi Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Sanofi Bacterial Vaginosis Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Sanofi Bacterial Vaginosis Drugs Products Offered
- 11.3.5 Sanofi Recent Development
- 11.4 Starpharma Holdings
- 11.4.1 Starpharma Holdings Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Starpharma Holdings Bacterial Vaginosis Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Starpharma Holdings Bacterial Vaginosis Drugs Products Offered
- 11.4.5 Starpharma Holdings Recent Development
12 Future Forecast
- 12.1 Bacterial Vaginosis Drugs Market Forecast by Regions
- 12.1.1 Global Bacterial Vaginosis Drugs Sales Forecast by Regions 2019-2025
- 12.1.2 Global Bacterial Vaginosis Drugs Revenue Forecast by Regions 2019-2025
- 12.2 Bacterial Vaginosis Drugs Market Forecast by Product
- 12.2.1 Global Bacterial Vaginosis Drugs Sales Forecast by Product 2019-2025
- 12.2.2 Global Bacterial Vaginosis Drugs Revenue Forecast by Product 2019-2025
- 12.3 Bacterial Vaginosis Drugs Market Forecast by End User
- 12.4 North America Bacterial Vaginosis Drugs Forecast
- 12.5 Europe Bacterial Vaginosis Drugs Forecast
- 12.6 Asia Pacific Bacterial Vaginosis Drugs Forecast
- 12.7 Central & South America Bacterial Vaginosis Drugs Forecast
- 12.8 Middle East and Africa Bacterial Vaginosis Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Bacterial Vaginosis Drugs Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Bacterial Vaginosis Drugs . Industry analysis & Market Report on Bacterial Vaginosis Drugs is a syndicated market report, published as Global Bacterial Vaginosis Drugs Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Bacterial Vaginosis Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
